It is currently known that the GPX1 expression level in tumor tissues is negatively correlated with the overall survival time of patients with breast, gastric, and glioma cancers and leukemia but is correlated with a favorable prognosis in pancreatic cancer patients (Table 2). This evidence concerns the gene GPX1 and familial pancreatic carcinoma.